ライフサイエンスコーパス: circulating blood

1 ive TF has been detected in vessel walls and circulating blood.

2 d the degradation products are detectable in circulating blood.

3 ion and platelet-neutrophil complexes in the circulating blood.

4 ll with platelets and coagulation factors in circulating blood.

5 urvival, as assayed by their contribution to circulating blood.

6 erves as a carrier for the plasma zymogen in circulating blood.

7 circulation to release pro/preplatelets into circulating blood.

8 h the number of RANKL + cells present in the circulating blood.

9 lycosylated SMPDL3A protein is detectable in circulating blood.

10 the prompt release of new platelets into the circulating blood.

11 sent in the lamina propria of the gut and in circulating blood.

12 es are filled with aqueous humor rather than circulating blood.

13 arrow and the nonadhesive environment of the circulating blood.

14 t microparticles are a normal constituent of circulating blood.

15 , which may occur on cell surfaces or in the circulating blood.

16 nly a small fraction of the concentration in circulating blood.

17 izeable yet underdeveloped organism requires circulating blood.

18 ching highly proliferative organs via, e.g., circulating blood.

19 ouse models using microarray (RNA) data from circulating blood, 2) blood microarray data can be used

20 f the absence of the heat sink effect of the circulating blood and covered a greater area (41+/-27 mm

21 ory and endothelial dysfunctional markers in circulating blood and directly in endothelial cells, whi

22 ches, representing T cell areas connected by circulating blood and lymph.

23 ) cells, positioned at the interface between circulating blood and lymphoid tissue, detect and respon

24 cells (ECs), forming a boundary between the circulating blood and the vessel wall, are constantly su

25 e ability of these agents to carry oxygen in circulating blood and their promise to improve oxygen de

26 tial to increase oxygen-carrying capacity of circulating blood and thus improve tissue oxygen deliver

27 integrity of the endothelial barrier between circulating blood and tissue is important for blood vess

28 ectives were to determine the form of MSP in circulating blood and to study proteolytic activation of

29 lack of spontaneous platelet aggregation in circulating blood, and a mechanism to limit thrombus for

30 e arising from nutrients and hormones in the circulating blood, as well as from contraction-induced s

31 of mature neutrophils within the BM and the circulating blood, as well as the role of microtubule re

32 the repertoire of IgA H chain transcripts in circulating blood B cells during human ontogeny.

33 Recent analyses of circulating blood B cells in myeloma have generated cont

34 However, the site of receptor stimulation-circulating blood-borne elements (ie, platelets) versus

35 e not only dependent on its concentration in circulating blood but also on its biological 'quality'.

36 ust be surgically reconfigured to act on the circulating blood, but little is known about the power l

37 bond contributes to platelet aggregation in circulating blood by permitting the formation of multipl

38 xoid matrix, which is in direct contact with circulating blood, can provide novel therapeutic avenues

39 in the valve were also found expanded in the circulating blood CD28(null)CD8(+) T cells and to a less

40 Circulating blood CD34(+) cells consist of hematopoietic

41 e the cloning of a GAP1(m) cDNA from a human circulating-blood cDNA library.

42 ival is associated with increased peripheral circulating blood cell counts and increased proliferativ

43 Circulating blood cell counts and indices are important

44 HSCs maintain the circulating blood cell population.

45 We aimed to describe the pivotal role that circulating blood cells (called hemocytes) play in immun

46 nnate immune mediators are either carried in circulating blood cells (ie, leukocytes and platelets) o

47 rAAV6 had a minimal effect on circulating blood cells and caused no apparent hepatotox

48 ) led to a potent reduction in the number of circulating blood cells and deficiency in hemoglobin pro

49 e is an intense interest in the potential of circulating blood cells and epithelium-related nonfibrob

50 otential prognostic/predictive biomarkers in circulating blood cells and in tumor-infiltrating lympho

51 expression of a single chemokine receptor on circulating blood cells and parenchymal cells is often u

52 Despite comparable levels of viral load in circulating blood cells and peripheral organs in the two

53 Circulating blood cells are exposed to soluble A beta1-4

54 Here we show that SNCA transcripts in circulating blood cells are paradoxically reduced in ear

55 ific knockout embryos had reduced numbers of circulating blood cells from E9.5 onwards, with the deve

56 e expression of membrane coagulant activity, circulating blood cells show decreased cell surface expo

57 They are initiated by abnormal adhesion of circulating blood cells to vascular endothelium of the m

58 Fluorescent circulating blood cells were detected in microinjected e

59 tion profile in placenta tissue, in maternal circulating blood cells, and in cord blood cells.

60 vel expression of both EKLF and PlGF mRNA in circulating blood cells, and markers of iron overload ar

61 in that could have an aggressive course with circulating blood cells, especially in Sezary syndrome a

62 ndition with enzyme impairment restricted to circulating blood cells, GALE deficiency was later demon

63 The kinetics of infection, circulating blood cells, granulopoiesis, lesions, and ce

64 Among circulating blood cells, the luciferase activity was exc

65 ticles were also found to be associated with circulating blood cells.

66 h muscle cells, reactive oxygen species, and circulating blood cells.

67 erm (less than 6 weeks) recovery kinetics of circulating blood cells.

68 lack GPI-linked proteins on a proportion of circulating blood cells.

69 ls (hemocytes) resulted in higher numbers of circulating blood cells.

70 ity of the bone marrow to produce sufficient circulating blood cells.

71 renewing multipotent cells that develop into circulating blood cells.

72 7-fold higher levels of EBV copy numbers in circulating blood cells.

73 ion, and fetal liver hematopoietic cells and circulating blood cells.

74 ters reduce cholesterol absorption and lower circulating blood cholesterol concentrations when incorp

75 by phagocytes and minimizes interaction with circulating blood components.

76 e Langerhans cells (LC) and some subtypes of circulating blood DC.

77 a local precursor rather than directly from circulating blood DCs or monocyte precursors.

78 expression of DC-SIGN in CD14+ monocytes and circulating blood DCs.

79 Quantification of cell-free DNA (cfDNA) in circulating blood derived from a transplanted organ is a

80 testinal tumors, finding that fusion between circulating blood-derived cells and tumor epithelium occ

81 pressed on endothelial cells (EC) as several circulating blood elements including platelets, polymorp

82 Despite the fact that circulating blood elements only received a fraction of t

83 en though PAH patients had normal numbers of circulating blood elements, hematopoietic alterations in

84 lial cells and between endothelial cells and circulating blood elements.

85 the vascular wall, and its interaction with circulating blood elements.

86 ates the interaction of the vessel wall with circulating blood elements.

87 have been developed to isolate the LAA from circulating blood flow, as an alternative to OAC.

88 croglia, the BBB separates components of the circulating blood from neurons.

89 The blood brain barrier separates the circulating blood from the extracellular fluid in the ce

90 Circulating blood generates frictional forces (shear str

91 B binding domain in CRTC2 (-/-) mice lowered circulating blood glucose concentrations and improved in

92 of a small-molecule KAT2B antagonist lowered circulating blood glucose concentrations in insulin resi

93 Circulating blood glucose levels affect ChREBP activity

94 treatment alone elicited a rapid decline in circulating blood glucose levels, which appeared to indu

95 nt and acquired microcephaly who have normal circulating blood glucose, low-to-normal cerebrospinal f

96 re likely than mutant cells to contribute to circulating blood in a wild-type host.

97 nearly all CD45(+) cells in bone marrow and circulating blood in adults were of Flk-1(+) origin.

98 significant increases of neutrophils in the circulating blood in both PKC-epsilon transgenic lines.

99 cell-derived EVs (E-EVs) are upregulated in circulating blood in different pathological conditions;

100 Cs) are present in very small numbers in the circulating blood in steady-state conditions.

101 s and rapidly clear viable cancer cells from circulating blood in the living mouse.

102 The complement system present in circulating blood is an effective mechanism of host defe

103 eutrophils from the bone marrow reserve into circulating blood, is important to increase peripheral n

104 viral labeling strategy, we demonstrate that circulating blood island-derived cells contribute to the

105 Finally, a transient rise in circulating blood leptin levels was detected within the

106 id concentrations and the absolute number of circulating blood leukocytes, lymphocytes, T cells, and

107 h different pattern recognition receptors in circulating blood leukocytes, triggering specific host t

108 al role in the transendothelial migration of circulating blood leukocytes.

109 differential responses in liver, spleen, and circulating blood leukocytes.

110 lation of lung neutrophils; lower numbers of circulating blood leukocytes; and an impaired febrile re

111 ence for and against the hypothesis that the circulating blood level of growth differentiation factor

112 ed results have shown an association between circulating blood levels of some insulin-like growth fac

113 important role in hippocampal functions than circulating blood levels.

114 rgans and cause a reduction in the number of circulating blood lymphocytes.

115 increase in hemodynamic resistance caused by circulating blood may be a factor.

116 Lower viral clearance rates in circulating blood may explain the phenomenon of increase

117 over, systemic upregulation of VEGF-A165b in circulating blood may have wider-ranging implications be

118 Circulating blood monocytes belong to the first line of

119 tion of IL-1beta and IL-18, and suggest that circulating blood monocytes constitutively express a P2X

120 Circulating blood monocytes from macFoxp1tg mice have re

121 The number of circulating blood monocytes impacts atherosclerotic lesi

122 Circulating blood monocytes supply peripheral tissues wi

123 now report on the isolation and analysis of circulating blood myeloid DCs, resulting from natural di

124 During this process, molecular signals guide circulating blood neutrophils to target specific vessels

125 tural killer T cells in the lungs and in the circulating blood of 14 patients with asthma.

126 er of activated/differentiated fibrocytes in circulating blood of asthmatic patients experiencing an

127 ith this, we observed 30% fewer monocytes in circulating blood of Ccr6(-/-)ApoE(-/-) mice, mainly bec

128 ighest in adipose tissue, mammary gland, and circulating blood of Cyp1a2(-/-) mothers, compared with

129 e reduced to barely detectable levels in the circulating blood of vaccinated animals.

130 eropositive man with Zostavax, we sorted his circulating blood plasma blasts and amplified expressed

131 uencing cell-free DNA (cfDNA), isolated from circulating blood plasma, we generated maps of genome-wi

132 Circulating blood platelets are specialized cells that p

133 Circulating blood platelets regulate the initial phase o

134 ough PN2/AbetaPP is enriched in brain and in circulating blood platelets, little is understood of its

135 expressed in brain and, outside the CNS, in circulating blood platelets.

136 Major differences exist in the circulating blood proteome of the bottlenose dolphin com

137 he endothelium, which is directly exposed to circulating blood stressors, has been examined for eNOS

138 Surprisingly, a proportion of circulating blood T cells, B cells, and natural killer c

139 in the vessel wall, there is a pool of TF in circulating blood that contributes to the propagation of

140 Because tissue miRNAs can be released into circulating blood, they also offer exciting new opportun

141 l for increasing oxygen-carrying capacity of circulating blood, they are excellent candidates for abu

142 the BM were stiffer than neutrophils in the circulating blood, using magnetic twisting cytometry.

143 ypovolemic rabbits were bled of 10% of their circulating blood volume (85 mL/kg) every 10 mins until

144 he microvasculature rather than reduction in circulating blood volume and oxygen delivery.

145 cardiac output and heart performance and the circulating blood volume were assessed using the indocya

146 Cardiac output, heart performance, and circulating blood volume were significantly decreased in

147 Hemoglobin, systemic oxygen delivery, circulating blood volume, and plasma levels of interleuk

148 tput and heart performance and increased the circulating blood volume.

149 of carbon monoxide was used to estimate the circulating blood volume.

150 of reductions in central venous pressure and circulating blood volume.

151 depleted of one third and one half of their circulating blood volumes, respectively, and were resusc

152 ously-infused CFSE-labeled erythrocytes from circulating blood was faster in msk(-/-) mice.

153 Collagen exposure to circulating blood was undetectable after laser injury.

154 s, and usually involves processing the whole circulating blood, we tested whether LA could substantia

155 f intracellular concentration and ex vivo in circulating blood were demonstrated.

156 adioactivity out of the peritoneal cavity to circulating blood, which cleared via urinary excretion,

157 efflux of NK and memory CD8 T cells from the circulating blood within minutes of IL-15 administration

158 miRNAs are abundant in circulating blood, yet it is not known whether, as a cla